198 related articles for article (PubMed ID: 37029310)
1. In silico analysis of differentially expressed-aberrantly methylated genes in breast cancer for prognostic and therapeutic targets.
Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
Clin Exp Med; 2023 Nov; 23(7):3847-3866. PubMed ID: 37029310
[TBL] [Abstract][Full Text] [Related]
2. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
3. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
4. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
[TBL] [Abstract][Full Text] [Related]
5. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis.
Cheng H; Liu Y; Chen G
BMC Urol; 2023 Aug; 23(1):135. PubMed ID: 37563710
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
9. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Zhang Y; Fang L; Zang Y; Xu Z
Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
[TBL] [Abstract][Full Text] [Related]
10. Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.
Huang CH; Han W; Wu YZ; Shen GL
Front Genet; 2022; 13():817656. PubMed ID: 35991567
[No Abstract] [Full Text] [Related]
11. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
Zhou Z; Wu B; Tang X; Ke R; Zou Q
Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
14. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
[TBL] [Abstract][Full Text] [Related]
15. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
17. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
18. Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools.
Oumeddour A
Medicine (Baltimore); 2023 Mar; 102(11):e33291. PubMed ID: 36930083
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of differentially expressed miRNA-related mRNAs and their prognostic value in breast carcinoma.
Zhang GM; Goyal H; Song LL
Oncol Rep; 2018 Jun; 39(6):2865-2872. PubMed ID: 29693181
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly methylated-differentially expressed genes and related pathways in cholangiocarcinoma.
Lin G; Xinhe Z; Haoyu T; Yiling L
Medicine (Baltimore); 2022 Jun; 101(25):e29379. PubMed ID: 35758372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
